362 filings
Page 18 of 19
8-K
wq1m3 zdl9
1 May 06
Dynavax Announces First Quarter 2006 Financial Results and Outlook
12:00am
8-K
bsk oash4
27 Apr 06
Dynavax Closes Acquisition of Rhein Biotech GmbH From Crucell
12:00am
8-K
6rn32u 2iky
24 Apr 06
Entry into a Material Definitive Agreement
12:00am
8-K
qrzos2
15 Mar 06
Dynavax Announces Fourth Quarter and Year-end 2005 Financial Results
12:00am
8-K
xvouqgk9 plltlnp0r54
21 Dec 05
Departure of Directors or Principal Officers
12:00am
8-K
njtnn8zsnub
8 Nov 05
Dynavax Appoints Nancy L. Buc, Former Fda Chief Counsel, to Its Board of Directors
12:00am
8-K
zh4c y92tl18fn1h
28 Oct 05
Dynavax Announces Third Quarter 2005 Financial Results
12:00am
8-K
ut53c0hod lgcn3ju
12 Oct 05
Dynavax Announces Pricing of Public Offering of Common Stock Under Shelf Registration Statement
12:00am
8-K
1pum57tco7fdad wi
23 Aug 05
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
0brq u6nzl
19 Aug 05
Dynavax Appoints Acclaimed Vaccine Pioneer DR. Stanley A. Plotkin to Board of Directors
12:00am
8-K
wdw5mb
28 Jul 05
Dynavax Announces Second Quarter 2005 Financial Results
12:00am
8-K
vi0cwsdowz
28 Apr 05
Dynavax Announces First Quarter 2005 Financial Results
12:00am
8-K
bjmvtnhsk5d44
18 Apr 05
Entry into a Material Definitive Agreement
12:00am
8-K
s13h97hx7n6gf1rd9u
18 Mar 05
Termination of a Material Definitive Agreement
12:00am
8-K
8s37z0b
15 Feb 05
Dynavax Announces Fourth Quarter and Year-end 2004 Financial Results and 2005 Outlook
12:00am
8-K
jwyz8eg9 49v6vhsy
26 Jan 05
Departure of Directors or Principal Officers
12:00am
8-K
bjj0ima3hl
5 Jan 05
Dynavax Appoints Deborah A. Smeltzer As Chief Financial Officer
12:00am
8-K
jjhgbou b7p7ddhnur4
8 Nov 04
Dynavax Announces Third Quarter 2004 Financial Results
12:00am
8-K
4u6ubhixmjc315
27 Aug 04
Entry into a Material Definitive Agreement
12:00am
8-K
tuzytz5 iwmdoe7vz
6 Aug 04
Dynavax Reports 2004 Second Quarter Results
12:00am